Skip to Content


In the US, Maxipime (cefepime systemic) is a member of the drug class fourth generation cephalosporins and is used to treat Bacteremia, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin or Soft Tissue Infection and Urinary Tract Infection.

US matches:

Ingredient matches for Maxipime


Cefepime is reported as an ingredient of Maxipime in the following countries:

  • China
  • Egypt
  • India
  • Lebanon
  • Oman
  • South Africa
  • Taiwan

Cefepime dihydrochloride monohydrate (a derivative of Cefepime) is reported as an ingredient of Maxipime in the following countries:

  • Australia
  • Austria
  • Belgium
  • Bulgaria
  • Canada
  • Chile
  • Croatia (Hrvatska)
  • Czech Republic
  • Ecuador
  • Estonia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Italy
  • Japan
  • Lithuania
  • New Zealand
  • Oman
  • Peru
  • Portugal
  • Spain
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.